What is PT-141?
PT-141 (Bremelanotide) is a melanocortin receptor agonist FDA-approved for treating hypoactive sexual desire disorder in women. Unlike ED drugs, it works on the nervous system to increase sexual desire in both men and women.
Key Benefits
💑 Libido Enhancement
Increases sexual desire through central nervous system
🧠Mental Arousal
Works on desire, not just physical function
👫 For Both Sexes
Effective for men and women
âš¡ Fast Acting
Effects within 1-2 hours
🎯 Different Mechanism
Works differently than Viagra/Cialis
✅ FDA-Approved
Approved for female sexual dysfunction
How It Works
PT-141 activates melanocortin receptors in the hypothalamus, affecting neural pathways involved in sexual arousal and desire. It works centrally rather than peripherally like PDE5 inhibitors.
Typical Dosing Protocol
Dose: 0.5-2.0 mg as needed
Administration: Subcutaneous injection 45-60 minutes before desired effect
Duration: Effects last 6-12 hours, use as needed
Research Support
Clinical trials led to FDA approval for PT-141 in women with HSDD. Studies show it effectively increases sexual desire and function in both men and women through central nervous system mechanisms.